calcium channel blockers

Pharma

Long-term CCB therapy linked to higher breast cancer risk

The long-term use of calcium-channel blockers is associated with a doubling of the risk of both invasive ductal carcinoma and invasive lobular carcinoma of the breast, according to a report published online Aug. 5 in JAMA Internal Medicine. This and other findings from a large population-based case-control study require confirmation in future research, because this […]